StockData
BeOne Medicines Ltd. logo

BeOne Medicines Ltd. (ONC) operating KPIs

ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)

Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –

BeOne Medicines other Collaboration Revenue ($M, FY17–FY22) ($M)

Form 10-Q / 10-K Collaboration Note

QuarterlyAnnual
Latest, Q3 2023
3
Period ended Sep 30, 2023
Change on a year earlier
+50.0%
2 in Q3 2022
History
20 quarters
Since Q2 2018
Sources
13
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Collaboration Revenue ($M, FY17–FY22) ($M)Year on yearSource
Q3 2023Sep 30, 20233+50.0%Form 10-Q (filed 2023-11-09) ↗
Q2 2023Jun 30, 20231.70–Form 10-Q (filed 2023-08-02) ↗
Q1 2023Mar 31, 20234.40-18.5%Form 10-Q (filed 2023-05-04) ↗
Q4 2022Dec 31, 20222.10–Form 10-K (filed 2023-02-27) ↗
Q3 2022Sep 30, 20222–Form 10-Q (filed 2023-11-09) ↗
Q2 2022Jun 30, 20220–Form 10-Q (filed 2023-08-02) ↗
Q1 2022Mar 31, 20225.40–Form 10-Q (filed 2023-05-04) ↗
Q4 2021Dec 31, 20210–Form 10-K (filed 2023-02-27) ↗
Q3 2021Sep 30, 20210–Form 10-Q (filed 2022-11-09) ↗
Q2 2021Jun 30, 20210–Form 10-Q (filed 2022-08-08) ↗
Q1 2021Mar 31, 20210–Form 10-Q (filed 2022-05-09) ↗
Q4 2020Dec 31, 20200-100.0%Form 10-K (filed 2022-02-28) ↗
Q3 2020Sep 30, 20200–Form 10-Q (filed 2020-11-05) ↗
Q2 2020Jun 30, 20200-100.0%Form 10-Q (filed 2020-08-06) ↗
Q4 2019Dec 31, 2019-150–Form 10-K (filed 2023-02-27) ↗
Q3 2019Sep 30, 20190–Form 10-Q (filed 2020-11-05) ↗

Cite this data

StockData. (2026). BeOne Medicines Other Collaboration Revenue ($M, FY17–FY22) ($M), quarterly Q2 2018–Q3 2023 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/rev_collab_other

See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.